Berkenblit Anna
Officer at ImmunoGen, Inc.
- Sold, on record
- $523k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Feb 24, 2020
- Form 144 notices
- 21
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ImmunoGen, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ImmunoGen, Inc.NoticeAug 31, 2023 2023
Filed to sell 50,000 shares ($788k)
Berkenblit Anna, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice ImmunoGen, Inc.NoticeSep 1, 2023 +1 day
Filed to sell 50,000 shares ($800k)
Berkenblit Anna, Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 144 notice ImmunoGen, Inc.NoticeSep 6, 2023 +5 days
Filed to sell 50,000 shares ($784k)
Berkenblit Anna, Officer
No 10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice ImmunoGen, Inc.NoticeSep 11, 2023 +5 days
Filed to sell 50,000 shares ($789k)
Berkenblit Anna, Officer
No 10b5-1 planFirst sale on recordFiling
- 5 Form 144 notice ImmunoGen, Inc.NoticeSep 13, 2023 +2 days
Filed to sell 100,000 shares ($1.6M)
Berkenblit Anna, Officer
No 10b5-1 planFirst sale on recordFiling
- 6 Form 144 notice ImmunoGen, Inc.NoticeSep 18, 2023 +5 days
Filed to sell 50,000 shares ($783k)
Berkenblit Anna, Officer
No 10b5-1 planFirst sale on recordFiling
- 7 Form 144 notice ImmunoGen, Inc.NoticeSep 19, 2023 +1 day
Filed to sell 547,888 shares ($8.8M)
Berkenblit Anna, Officer
No 10b5-1 planFirst sale on recordFiling
- 8 Form 144 notice ImmunoGen, Inc.NoticeNov 2, 2023 +44 days
Filed to sell 109,435 shares ($1.6M)
Berkenblit Anna, Officer
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (27)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2023 | Nov 2, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 109,435 | $1.6M | Notice | SEC | |
| Sep 19, 2023 | Sep 19, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 547,888 | $8.8M | Notice | SEC | |
| Sep 18, 2023 | Sep 18, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $783k | Notice | SEC | |
| Sep 13, 2023 | Sep 13, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 100,000 | $1.6M | Notice | SEC | |
| Sep 11, 2023 | Sep 11, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $789k | Notice | SEC | |
| Sep 6, 2023 | Sep 6, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $784k | Notice | SEC | |
| Sep 1, 2023 | Sep 1, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $800k | Notice | SEC | |
| Aug 31, 2023 | Aug 31, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $788k | Notice | SEC | |
| Aug 30, 2023 | Aug 30, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $795k | Notice | SEC | |
| Aug 29, 2023 | Aug 29, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $798k | Notice | SEC | |
| Aug 28, 2023 | Aug 28, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $767k | Notice | SEC | |
| Aug 25, 2023 | Aug 25, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $798k | Notice | SEC | |
| Aug 24, 2023 | Aug 24, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $801k | Notice | SEC | |
| Aug 23, 2023 | Aug 23, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $825k | Notice | SEC | |
| Aug 22, 2023 | Aug 22, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $818k | Notice | SEC | |
| Aug 21, 2023 | Aug 21, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $788k | Notice | SEC | |
| Aug 18, 2023 | Aug 18, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $788k | Notice | SEC | |
| Aug 17, 2023 | Aug 17, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $790k | Notice | SEC | |
| Aug 16, 2023 | Aug 16, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $792k | Notice | SEC | |
| Aug 15, 2023 | Aug 15, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $777k | Notice | SEC | |
| Aug 14, 2023 | Aug 14, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 50,000 | $746k | Notice | SEC | |
| Feb 24, 2020 | Feb 25, 2020 | ImmunoGen, Inc. | SVP & Chief Medical Officer | Form 4 sale | 25,803 | $129k | 20.8% | Plan not stated | SEC |
| Oct 16, 2018 | Oct 17, 2018 | ImmunoGen, Inc. | VP & Chief Medical Officer | Form 4 sale | 5,851 | $47k | 4.2% | Plan not stated | SEC |
| Sep 10, 2018 | Sep 11, 2018 | ImmunoGen, Inc. | VP & Chief Medical Officer | Form 4 sale | 5,851 | $55k | 4.0% | Plan not stated | SEC |
| Feb 22, 2018 | Feb 25, 2019 | ImmunoGen, Inc. | VP & Chief Medical Officer | Form 4 sale | 16,562 | $93k | 12.2% | Plan not stated | SEC |
| Feb 21, 2018 | Feb 23, 2018 | ImmunoGen, Inc. | VP & Chief Medical Officer | Form 4 sale | 17,329 | $189k | 10.7% | Plan not stated | SEC |
| Sep 13, 2017 | Sep 18, 2017 | ImmunoGen, Inc. | VP & Chief Medical Officer | Form 4 sale | 1,500 | $11k | 0.9% | Plan not stated | SEC |